ROIV Roivant Sciences PE ratio, current and historical analysis

The current PE ratio of ROIV can't be determined, as the TTM EPS of -$0.24 is negative. The last PE ratio of Roivant Sciences, recorded in September 2024, was 1.94.

ROIV PE ratio history

How has ROIV's PE ratio performed in the past

Today

N/A

Average

N/A

Median

N/A

Minimum

N/A

Maximum

N/A

Roivant Sciences PE ratio by year

Year	PE ratio	PE change	Price	EPS
2025	N/A	N/A	$10.09	-$0.24
2024	1.9	N/A	$10.54	$5.55
2023	N/A	N/A	$7.38	-$1.42
2022	N/A	N/A	$4.94	-$1.26
2021	N/A	N/A	$9.78	-$1.28
2020	N/A	N/A	N/A	$5.13

Roivant Sciences PE ratio by quarter (TTM)

Year	PE ratio	PE change	Price	EPS
Mar 2025	N/A	N/A	$10.09	-$0.24
Dec 2024	N/A	N/A	$11.83	-$0.19
Sep 2024	1.94	7.78%	$11.54	$5.95
Jun 2024	1.8	-5.26%	$10.57	$5.86
Mar 2024	1.9	-5.94%	$10.54	$5.55
Dec 2023	2.02	N/A	$11.23	$5.56
Sep 2023	N/A	N/A	$11.68	-$1.3
Jun 2023	N/A	N/A	$10.08	-$1.32
Mar 2023	N/A	N/A	$7.38	-$1.42
Dec 2022	N/A	N/A	$7.99	-$1.78
Sep 2022	N/A	N/A	$3.22	-$1.7
Jun 2022	N/A	N/A	$4.07	-$1.6
Mar 2022	N/A	N/A	$4.94	-$1.26
Dec 2021	N/A	N/A	$10.08	-$1.66
Sep 2021	N/A	N/A	$9.35	-$1.66

ROIV Price vs fair value

How does ROIV's price compare to its estimated fair value based on its growth

ROIV average PE ratio chart

What is the average PE ratio of ROIV for the past years

3-year avg

N/A

5-year avg

N/A

10-year avg

N/A

15-year avg

N/A

ROIV PE vs peers

What is ROIV's PE ratio compared to its peers

Stock name	PE ratio	Market cap
OLMA Olema Pharmaceuticals Inc	N/A	$280.53M
OMER Omeros Corp	N/A	$188.67M
VIVS VivoSim Labs Inc.	N/A	$3.67M
ORIC Oric Pharmaceuticals Inc	N/A	$655.43M
ORMP Oramed Pharmaceuticals Inc	N/A	$87.83M
ROIV Roivant Sciences Ltd	N/A	$7.78B

Frequently asked questions

What is Roivant Sciences's PE ratio?

The current price to earnings ratio of ROIV can't be calculated, as its EPS of -$0.24 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.